Literature DB >> 11198270

Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls.

M T Fahey1, G S Hamada, I N Nishimoto, L P Kowalski, K Iriya, J J Gama-Rodrigues, S Tsugane.   

Abstract

A low level of serum pepsinogen I (Pg I) is a risk factor for gastric cancer (GC); low levels of Pg I and the pepsinogen ratio (Pg I:Pg II) are correlated with chronic atrophic gastritis. We report serum Pg levels and compare the degree of association with GC among Japanese and non-Japanese Brazilians. Sera were cross-sectionally ascertained from 93 Japanese Brazilian patients category matched by age and sex with 110 controls, and 228 non-Japanese Brazilian patients individually matched by age and sex with one control. Among non-Japanese Brazilians, GC was associated with a Pg I level <30 ng/ml (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.7-3.8) and a Pg I:Pg II ratio < 3.0 (OR, 3.4; 95% CI, 2.2-5.3). However, among Japanese Brazilians, the association was present with a level of Pg I < 30 ng/ml (OR, 3.5; 95% CI, 1.9-6.3), and was weak with a Pg I:Pg II ratio < 3.0 (OR, 1.3; 95% CI, 0.73-2.4). Serum Pg I may be preferred to the Pg I:Pg II ratio to study the association between Pg and GC among Japanese Brazilians.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198270

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  6 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

2.  Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.

Authors:  Pei-Fang Ning; Hui-Jie Liu; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

3.  Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.

Authors:  Mário Dinis-Ribeiro; Altamiro da Costa-Pereira; Carlos Lopes; Joana Barbosa; Mateus Guilherme; Luís Moreira-Dias; Helena Lomba-Viana; Rui Silva; Nuno Abreu; Rafael Lomba-Viana
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

4.  The Impact of Gastric Atrophy on the Incidence of Diabetes.

Authors:  Tse-Ya Yu; Jung-Nan Wei; Chun-Heng Kuo; Jyh-Ming Liou; Mao-Shin Lin; Shyang-Rong Shih; Cyue-Huei Hua; Yenh-Chen Hsein; Ya-Wen Hsu; Lee-Ming Chuang; Mei-Kuei Lee; Ching-Hsiang Hsiao; Ming-Shiang Wu; Hung-Yuan Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

5.  Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in São Paulo.

Authors:  N Fujioka; M T Fahey; G S Hamada; I N Nishimoto; L P Kowalski; K Iriya; J J Rodrigues; H Tajiri; S Tsugane
Journal:  Jpn J Cancer Res       Date:  2001-08

6.  Low pepsinogen I level predicts multiple gastric epithelial neoplasias for endoscopic resection.

Authors:  Seon Young Park; Sung Ook Lim; Ho Seok Ki; Chung Hwan Jun; Chang Hwan Park; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.